Reaction Details |
![](/images/Email.png) | Report a problem with these data |
Target | CB1 cannabinoid receptor-interacting protein 1 |
---|
Ligand | BDBM646495 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | CB1 and CB2 Binding Inhibition by Compounds Purified from Milicia excelsa (African Teak) |
---|
IC50 | 3500±n/a nM |
---|
Citation | Brownell, LA; Choi, B; Corneliusen, B; Hong, M; Hyun, E; Jia, Q; Jiao, P; Kim, H; Kim, M; Kim, T; Lee, B; Lee, Y; Nam, J; Yimam, M; Hwang, J; Oh, M Compositions and Methods for Managing Weight US Patent US20240024403 Publication Date 1/25/2024 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
CB1 cannabinoid receptor-interacting protein 1 |
---|
Name: | Cannabinoid receptor 1 |
Synonyms: | CANN6 | CANNABINOID CB1 | CB-R | CB1 | CNR | CNR1 | CNR1_HUMAN | Cannabinoid CB1 receptor | Cannabinoid receptor | Cannabinoid receptor 1 (CB1) | Cannabinoid receptor 1 (brain) |
Type: | G Protein-Coupled Receptor (GPCR) |
Mol. Mass.: | 52868.96 |
Organism: | Homo sapiens (Human) |
Description: | P21554 |
Residue: | 472 |
Sequence: | MKSILDGLADTTFRTITTDLLYVGSNDIQYEDIKGDMASKLGYFPQKFPLTSFRGSPFQE
KMTAGDNPQLVPADQVNITEFYNKSLSSFKENEENIQCGENFMDIECFMVLNPSQQLAIA
VLSLTLGTFTVLENLLVLCVILHSRSLRCRPSYHFIGSLAVADLLGSVIFVYSFIDFHVF
HRKDSRNVFLFKLGGVTASFTASVGSLFLTAIDRYISIHRPLAYKRIVTRPKAVVAFCLM
WTIAIVIAVLPLLGWNCEKLQSVCSDIFPHIDETYLMFWIGVTSVLLLFIVYAYMYILWK
AHSHAVRMIQRGTQKSIIIHTSEDGKVQVTRPDQARMDIRLAKTLVLILVVLIICWGPLL
AIMVYDVFGKMNKLIKTVFAFCSMLCLLNSTVNPIIYALRSKDLRHAFRSMFPSCEGTAQ
PLDNSMGDSDCLHKHANNAASVHRAAESCIKSTVKIAKVTMSVSTDTSAEAL
|
|
|
BDBM646495 |
---|
n/a |
---|
Name | BDBM646495 |
Synonyms: | US20240024403, Compound Sanggenon |
Type | Small organic molecule |
Emp. Form. | C40H36O12 |
Mol. Mass. | 708.7066 |
SMILES | [#6]\[#6](-[#6])=[#6]/[#6]C12[#8]-c3c(-[#6]-4-[#6]=[#6](-[#6])-[#6]-[#6](-[#6]-4-[#6](=O)-c4ccc(-[#8])cc4-[#8])-c4ccc(-[#8])cc4-[#8])c(-[#8])cc(-[#8])c3-[#6](=O)C1([#8])[#8]-c1cc(-[#8])ccc21 |t:10| |
Structure |
|